Donet Main, DO
Adult Reconstructive Orthopaedic Surgery · Macon, MONPI 1861409625
Payments from drug & device makers
What this record shows
This record is dominated by education: $3,529 of the $5,492 with a category attached, or 64.3%. 19 manufacturers reported payments, led by Elite Orthopedics, LLC at 47.6% of the total. Reporting peaked in 2019 at $1,867 and has fallen 63.5% since, to $682 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in MO, where the typical reported total is $10,569.
Across 51 payments — averaging $107.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elite Orthopedics, LLC$3K
- Arthrex$2K
- Imbed Biosciences Inc.$577
- Heron Therapeutics, Inc.$85
- Stryker$72
- Fidia Pharma USA Inc.$54
- plus $305 from 13 others
What the payments were for
- Travel & lodging$4107%
- Food & beverage$1,55328%
- Education$3,52964%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elite Orthopedics, LLC | 12 | $2,613 |
| Arthrex | 6 | $1,786 |
| Imbed Biosciences Inc. | 10 | $577 |
| Heron Therapeutics, Inc. | 2 | $85 |
| Stryker | 1 | $72 |
| Fidia Pharma USA Inc. | 3 | $54 |
| Vertex | 2 | $49 |
| Organogenesis Inc. | 3 | $48 |
| Radius Health, Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $25 |
| Zimmer Biomet | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 2 | $23 |
| Revance Therapeutics, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $18 |
| Linvatec Corporation | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Celularity Inc. | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
How this compares
$5,492 in reported general payments places this provider in the 30th percentile of 36 adult reconstructive orthopaedic surgery providers in Missouri.
See all adult reconstructive orthopaedic surgery providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $4,009 |
| Celecoxib | 115 | $2,751 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 78 | $1,986 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 55 | $665 |
| Meloxicam | 148 | $387 |
| Tramadol Hcl | 48 | $231 |
| Cephalexin | 35 | $195 |
| Amitriptyline Hcl | 12 | $135 |
| Pregabalin | 25 | $122 |
| Gabapentin | 12 | $91 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Macon
- Robert BarrackSaint Louis$10.6M
- Ryan NunleySaint Louis$3.9M
- Thomas AletoColumbia$669K
- John ClohisySaint Louis$538K
- Kimberly BartosiakSaint Louis$92K
- Ajay AggarwalColumbia$78K
- Ilya BendichSaint Louis$78K
- Muyibat AdelaniSaint Louis$71K
- Parth VyasSaint Louis$47K
- Katherine MistrettaSaint Louis$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.